At this concentration, TWEAK failed to induce significant IκBα degradation and nuclear translocation of RelA (see Figure 3B), suggesting minimal TWEAK-induced activation of the canonical NF-κB pathway in glioma cells. Here, NFKB1 is linked to central nervous system cancer.